IA

Isabella Attinger-Toller

Chief Technology Officer (CTO)

Araris Biotech AG

Zuerich, Zurich


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Araris Biotech AG
Industry
research
Employees
22.0
Seniority
C suite
Annual Revenue
4000000.0
Total Funding
46255006.0
Latest Funding
Other

Technologies

Microsoft Office 365 Google Analytics Google Tag Manager Google Font API Apache Mobile Friendly Render AI

Keywords

antibody drug conjugates & adcs biotechnology research antibody-drug conjugates adc technology linker technology biopharmaceuticals payload delivery cancer therapy homogenous adcs stable adcs site-specific modification peptide linkers cancer cell targeting therapeutic index bioconjugation drug stability hydrophilic linkers manufacturing efficiency one-step conjugation hydrophobic payloads adc aggregation biological efficacy pharmaceutical development clinical research pharmacokinetics preclinical studies immunotherapy drug design pharmaceutical r&d cancer treatment disease-targeted therapies api delivery systems dual-targeting adcs antibody engineering enzymatic conjugation transglutaminase technology precision medicine novel therapeutics drug delivery systems biotechnology startups pharmaceutical innovation cancer immunology patent portfolio research collaboration drug discovery clinical trials oncology advancements therapeutic candidates pharmaceutical partnerships investor syndicate health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans